EpiQuil showcases its technology at UNSW Investor Showcase

Written by Helene Klein

EpiQuil presented its dissolving microneedle drug delivery platform at the UNSW Investor Showcase, connecting with investors and industry stakeholders and demonstrating its approach to delivering complex medicines through the skin.

Helene Klein
Next

EpiQuil receives ethics approval for preclinical pharmacokinetic study